Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Call to stop exposing women to breast cancer risk by needlessly using radiation therapy as a component of Hodgkin disease treatment

Young women who are treated for Hodgkin lymphoma with chest radiation therapy have a high cumulative absolute risk of developing breast cancer later in life. This risk increases with age at end of follow-up, time since diagnosis, and radiation dose, according to a new study in the October 5 issue of the Journal of the National Cancer Institute.

4 Oct 2005

Compound called GRN163L blocks lung cancer

Researchers at UT Southwestern Medical Center have found a compound that shows promise as a way to block the spread, or metastasis, of lung cancer.

1 Sep 2005

Danish scientists have identified which head and neck cancer patients will benefit from additional drug treatment during radiotherapy

Tumours that have low concentrations of oxygen (hypoxia) are resistant to radiotherapy. A drug called nimorazole (a hypoxia radiosensitiser) can improve the outcome of radiotherapy for patients with these types of tumours. However, at the moment there is no way to identify people with tumours that lack oxygen, who need this additional drug treatment, from those that only need radiotherapy.

30 Aug 2005

Discovery may significantly advance the treatment of cancers and infectious diseases

Current treatments frequently achieve only limited results with these types of diseases, which affect hundreds of thousands of Canadians.

29 Aug 2005

Best treatment for the immobilizing trauma of spinal cord compression in metastatic cancer

In this week's Lancet, Patchell's UK research team evaluate traditional surgical and radiation therapy options and conclude that direct decompressive surgery plus postoperative radiotherapy is more effective than either radiotherapy alone or other surgical options.

22 Aug 2005

Good news for the hundreds of thousands of cancer patients who undergo radiation therapy

Scientists report that they have a better understanding of the complex effects of radiation on tumor biology and that specific radiation treatment regimens may enhance the effectiveness of radiotherapy, even in tumor populations that have been notoriously difficult to treat.

16 Aug 2005

Giving prostate cancer patients radiotherapy after surgery could help prevent the progression of their disease

When cancer is confined to the prostate, removal of the organ can successfully control the disease. However, for patients with cancer extending beyond the prostate the risk of recurrence after surgery can be 10–50%.

11 Aug 2005

Australian scientists rejuvenate the immune systems of mice and humans using a common hormone

The scientists, led by Associate Professor Richard Boyd and Dr Jayne Sutherland from the Monash Immunology and Stem Cell Laboratories, have revitalised the thymus which produces the T cells required to fight infection but which shuts down from early adulthood.

11 Aug 2005

Hospital funding gives radiotherapy cancer boost

Australia's state of Victoria will continue to treat all urgent radiotherapy patients within 48 hours, with an additional $8.9 million for state-of-the-art equipment, Health Minister Bronwyn Pike announced.

2 Aug 2005

Many testicular cancer patients are able to father children

According to Dr Robert Huddart of the Institute of Cancer Research in London, the vast majority of men, after testicular cancer treatment, can go on and have a family as normal.

23 Jul 2005

One shot testicular cancer drug as good as radiotherapy

A single dose of the drug carboplatin is as effective at treating testicular cancer as two to three weeks of radiotherapy.

23 Jul 2005

One-day treatment with the anticancer drug carboplatin is as effective as radiotherapy for testicular cancer

One-day treatment with the anticancer drug carboplatin is as effective and less toxic than three weeks radiation therapy for a type of testicular cancer, according to a report published in this week’s issue of The Lancet.

21 Jul 2005

Fertility boost for testicular cancer patients

The vast majority of men who try to have a family, following treatment for testicular cancer, are able to father children - according to a report published today in the British Journal of Cancer.

21 Jul 2005

$New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer$

New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer

When breast cancer spreads to bones, relatively new protective drugs called bisphosphonates can reduce skeletal damage, says a new systematic review of previous studies. While the new treatment approach does not improve survival rates, it can minimize disabling fractures, spinal cord compression and pain.

19 Jul 2005

Cancer patients are being forced to bear the massive financial burden of changes in NHS treatment

The side effects of cancer treatment mean patients often have to give up work, and may have to live on a low income; forcing many patients to make a choice between finding the money for travel to hospital and basic necessities such as food, children's clothes and household bills.

19 Jul 2005

Some men with breast cancer may be having unnecessary radiotherapy

A study carried out at the British Columbia Cancer Agency in Vancouver, British Columbia, Canada, showed that men whose cancer had not spread beyond the breast were almost six times more likely to be given radiotherapy than were women with the equivalent stage of disease.

21 Jun 2005

For men diagnosed with prostate cancer, there is no risk of recurrence if external beam radiation therapy (EBRT) is delayed by several months

A study published in the July 15, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, finds delays of EBRT had no harmful impact on clinical outcome or biochemical marker levels in low-, intermediate- and high-risk patients.

13 Jun 2005

Experts call for more research into treatments for children's brain tumours

More independent study is needed into the biology of children's brain tumours if effective treatments are to be developed, experts at The University of Nottingham have said in a leading journal.

10 Jun 2005

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Schering-Plough announced today that the European Commission has granted approval of Temodal (temozolomide) Capsules for first-line use for the treatment of patients with newly diagnosed glioblastoma multiforme (GBM), the most common and aggressive form of primary brain cancer.